Cargando...
DNA methylation of Hugl‐2 is a prognostic biomarker in kidney renal clear cell carcinoma
It has been reported that loss of Hugl‐2 contributes to tumour formation and progression in vitro and in vivo. However, whether Hugl‐2 levels decrease during kidney renal clear cell carcinoma (KIRC) and the mechanism involved remain unknown. This study aimed to investigate whether DNA methylation of...
Guardado en:
| Publicado en: | Clin Exp Pharmacol Physiol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7821335/ https://ncbi.nlm.nih.gov/pubmed/32754907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1440-1681.13390 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|